BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17583464)

  • 1. Role of xenobiotic efflux transporters in resistance to vincristine.
    Huang RS; Murry DJ; Foster DR
    Biomed Pharmacother; 2008 Feb; 62(2):59-64. PubMed ID: 17583464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
    Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines.
    Huang R; Murry DJ; Kolwankar D; Hall SD; Foster DR
    Biochem Pharmacol; 2006 Jun; 71(12):1695-704. PubMed ID: 16620787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects.
    Depeille P; Cuq P; Mary S; Passagne I; Evrard A; Cupissol D; Vian L
    Mol Pharmacol; 2004 Apr; 65(4):897-905. PubMed ID: 15044619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine.
    Baran Y; Gunduz U; Ural AU
    Exp Oncol; 2006 Jun; 28(2):163-5. PubMed ID: 16837911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influx and efflux transport as determinants of melphalan cytotoxicity: Resistance to melphalan in MDR1 overexpressing tumor cell lines.
    Kühne A; Tzvetkov MV; Hagos Y; Lage H; Burckhardt G; Brockmöller J
    Biochem Pharmacol; 2009 Jul; 78(1):45-53. PubMed ID: 19447222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of regulatory proteins in L1210/VCR cells with multidrug resistance mediated by P-glycoprotein.
    Barancík M; Bohácová V; Zbýnovcová M; Breier A
    Gen Physiol Biophys; 1999 Mar; 18(1):45-56. PubMed ID: 10378120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
    He Y; Zhang J; Zhang J; Yuan Y
    Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
    Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
    Hira A; Watanabe H; Maeda Y; Yokoo K; Sanematsu E; Fujii J; Sasaki J; Hamada A; Saito H
    Biochem Pharmacol; 2008 Feb; 75(4):973-80. PubMed ID: 18054347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
    Yatouji S; El-Khoury V; Trentesaux C; Trussardi-Regnier A; Benabid R; Bontems F; Dufer J
    Int J Oncol; 2007 Apr; 30(4):1003-9. PubMed ID: 17332941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincristine-induced overexpression of P-glycoprotein in L1210 cells is associated with remodeling of cell surface saccharides.
    Sulová Z; Mislovicová D; Gibalová L; Vajcnerová Z; Poláková E; Uhrík B; Tylková L; Kovarova A; Sedlák J; Breier A
    J Proteome Res; 2009 Feb; 8(2):513-20. PubMed ID: 19099507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional nanoassemblies for vincristine sulfate delivery to overcome multidrug resistance by escaping P-glycoprotein mediated efflux.
    Zhang P; Ling G; Sun J; Zhang T; Yuan Y; Sun Y; Wang Z; He Z
    Biomaterials; 2011 Aug; 32(23):5524-33. PubMed ID: 21546082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein.
    Pop I; Pop L; Vitetta ES; Ghetie MA
    Oncol Rep; 2008 Apr; 19(4):889-95. PubMed ID: 18357372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (99m)Tc-MIBI imaging for prediction of therapeutic effects of second-generation MDR1 inhibitors in malignant brain tumors.
    Sasajima T; Shimada N; Naitoh Y; Takahashi M; Hu Y; Satoh T; Mizoi K
    Int J Cancer; 2007 Dec; 121(12):2637-45. PubMed ID: 17708555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines.
    Siissalo S; Laitinen L; Koljonen M; Vellonen KS; Kortejärvi H; Urtti A; Hirvonen J; Kaukonen AM
    Eur J Pharm Biopharm; 2007 Sep; 67(2):548-54. PubMed ID: 17475454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.